Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 13, 2006
Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary interventionRaymond I Huang, Parul Patel, Paul Walinsky, et al.
American Journal of Infection Control|October 4, 2014
Multidrug-resistant organisms contaminating supply carts of contact isolation patientsShane Zelencik, Donna Schora, Adrienne Fisher, et al.
British Journal of Clinical Pharmacology|January 15, 2017
Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult womenChristine Trezza, Susan L Ford, Elizabeth Gould, et al.
The Journal of Antimicrobial Chemotherapy|April 16, 2011
Pharmacokinetics of the HIV integrase inhibitor S/GSK1349572 co-administered with acid-reducing agents and multivitamins in healthy volunteersParul Patel, Ivy Song, Julie Borland, et al.
Clinical Pharmacology in Drug Development|February 28, 2019
A Phase I Study to Evaluate the Pharmacokinetics and Safety of Cabotegravir in Adults With Severe Renal Impairment and Healthy Matched Control ParticipantsRidhi Parasrampuria, Susan L Ford, Yu Lou, et al.
AIDS (London, England)|August 2, 2008
First large, multicenter, open-label study utilizing HLA-B*5701 screening for abacavir hypersensitivity in North AmericaBenjamin Young, Kathleen Squires, Parul Patel, et al.
Journal of Clinical Pharmacology|October 20, 2015
Application of a Stable Isotope Approach to Evaluate Impact of Changes in Manufacturing Parameters for an Immediate-Release TabletAlan Parr, Geoff Badman, Chester L Bowen, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2007
Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infantsAdriana H Tremoulet, Edmund V Capparelli, Parul Patel, et al.
The Journal of Antimicrobial Chemotherapy|July 29, 2025
Hypertension and blood pressure changes with dolutegravir or comparator antiretroviral therapy in randomized trials through 96 weeksParul Patel, Ana Milinkovic, Richard Grove, et al.
Pageof 10